A judge ruled that the Trump administration has not provided sufficient evidence to justify labeling AI company Anthropic as a supply chain risk and banning its technology from federal use. The dispute arises from stalled contract talks between Anthropic and the Department of Defense, with Anthropic opposing the use of its AI for mass surveillance or lethal weapon decisions. The judge criticized the government’s reasoning, warning it could set a precedent against contractors who disagree with the administration. The ruling temporarily blocks the ban while the judge considers making it permanent.
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...
Pomerantz LLP has filed a class action lawsuit against Anavex Life Sciences Corp. following the abrupt firing of its CEO for cause and the company's disclosure of a material weakness in financial controls. The CEO's termination announcement caused a ...
